The March/April 2026 issue of Topics in Antiviral Medicine™ (TAM) is now available

The March/April 2026 issue of Topics in Antiviral Medicine™ (TAM) is now available at https://www.iasusa.org/tam/march-april-2026/. This issue offers up to 12.25 CME credits and includes 9 articles showcasing the latest data from the 2026 Conference on Retroviruses and Opportunistic Infections.

Selected Highlights of the 2026 Conference on Retroviruses and Opportunistic Infections

• CROI 2026: Basic Science Highlights From the 2026 Conference on Retroviruses and Opportunistic Infections
  Mario Stevenson, PhD

• CROI 2026: Neuro-HIV at the Crossroads of Coinfections, Reservoirs, ART, and Comorbidities
  Michael J. Corley, MA PhD, Sarah B. Joseph, PhD, Phillip Chan, MBChB, PhD

• CROI 2026: Antiretroviral Therapy in Adult, Maternal, and Pediatric Populations With HIV
  Shauna H Gunaratne, MD, MPH, DTM&H, Timothy J. Wilkin, MD, MPH, Hong-Van Tieu, MD, MS

• CROI 2026: Innovations in HIV Care and Service Delivery to Improve Treatment Outcomes
  Barbara S. Taylor, MD, MS

• CROI 2026: Tuberculosis and Other Infectious Complications in People With HIV
  Andrew D. Kerkhoff, MD, PhD, Jason Zucker, MD, Diane V. Havlir, MD

• CROI 2026: Advances in Epidemiology and Treatment of Viral Hepatitis
  Shauna H. Gunaratne, MD, MPH, DTM&H

• CROI 2026: HIV Comorbidities
  Sudipa Sarkar, MD, Todd T. Brown, MD, PhD

• CROI 2026: Acute and Postacute COVID-19
  Annukka A. R. Antar, MD, PhD

• CROI 2026: Global Epidemiology and Prevention of HIV and Other Sexually Transmitted Diseases
  Susan P. Buchbinder, MD, Albert Y. Liu, MD, MPH

Continuing Education

The International Antiviral Society–USA (IAS–USA) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. The IAS–USA designates this issue for a maximum of 12.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.